Vivani Medical (FRA:U5P) ROCE % : -56.87% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Vivani Medical ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Vivani Medical's annualized ROCE % for the quarter that ended in Mar. 2024 was -56.87%.

Vivani Medical ROCE % Historical Data

The historical data trend for Vivani Medical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivani Medical ROCE % Chart

Vivani Medical Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

ROCE %

-304.90

-430.96

-89.50

-62.94

Vivani Medical Quarterly Data
	Dec20	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial								-63.24	-61.10	-58.54	-57.19	-56.87

Vivani Medical ROCE % Calculation

Vivani Medical's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-24.727	/	( ( (48.267 - 6.44)	+	(41.996 - 5.248) )	/ 2 )
	=	-24.727	/	( (41.827	+	36.748)	/ 2 )
	=	-24.727	/	39.2875
	=	-62.94 %

Vivani Medical's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-22.916	/	( ( (41.996 - 5.248)	+	(49.485 - 5.647) )	/ 2 )
	=	-22.916	/	( ( 36.748	+	43.838 )	/ 2 )
	=	-22.916	/	40.293
	=	-56.87 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Vivani Medical (FRA:U5P) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Vivani Medical ROCE % Related Terms

Thank you for viewing the detailed overview of Vivani Medical's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vivani Medical (FRA:U5P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vivani Medical Inc (FRA:U5P) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

VANI:USA

Address

5858 Horton Street, Suite 280, Emeryville, CA, USA, 94608

Website

https://www.vivani.com

Vivani Medical Inc is a preclinical stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases.

Vivani Medical (FRA:U5P) Headlines

No Headlines